Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,736 public trials 631 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Study Of Asthma In Patients Of African Descent

NCT00102765

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
View all 75 locations
View Trial Details
Completed

Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis

NCT01086410

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Cypress, California, United States
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
  • GSK Investigational Site San Antonio, Texas, United States
View all 17 locations
View Trial Details
Completed

Fall Epidemic Viral Pediatric Study

NCT01192178

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Fresno, California, United States
  • GSK Investigational Site Granada Hills, California, United States
View all 38 locations
View Trial Details
Completed

HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents

NCT01147848

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Riverside, California, United States
View all 63 locations
View Trial Details
Completed

Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response

NCT01128569

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Berlin, State of Berlin, Germany
  • GSK Investigational Site Wellington, New Zealand
  • GSK Investigational Site London, United Kingdom
  • GSK Investigational Site Manchester, United Kingdom
View Trial Details
Completed

Acetaminophen Versus Ibuprofen in Children With Asthma

NCT01606319

Conditions
Asthma, Body Temperature Changes, Bronchial Diseases, +15 more
Locations
  • University of Arizona College of Medicine Tucson, Arizona, United States
  • Children's Hospital & Research Center Oakland Oakland, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • National Jewish Health Denver, Colorado, United States
View all 15 locations
View Trial Details
Completed

A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis

NCT00682643

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations
  • GSK Investigational Site Oxford, Alabama, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Fresno, California, United States
  • GSK Investigational Site Huntington Beach, California, United States
View all 56 locations
View Trial Details
Completed

Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects

NCT01453296

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Cypress, California, United States
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Normal, Illinois, United States
View Trial Details

Related conditions